Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Oct 2016
At a glance
- Drugs Dapagliflozin (Primary) ; Glimepiride (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 04 Nov 2008 Actual patient number (11) added as reported by ClinicalTrials.gov.
- 04 Nov 2008 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
- 04 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.